Allie Stanton

Phd Candidate - Pardis Sabeti Lab

Harvard Medical School

Amber Van Laar

Vice President, Clinical Development


Amy Brin

Executive Director & CEO

The Child Neurology Foundation

Anindya Sen

Director - Pre-Clinical Research & Development

Prevail Therapeutics

Anna Kajaste-Rudnitski

Group Leader

San Raffaele Hospital

Ben Deverman

Director of Vector Engineering, Stanley Center for Psychiatric Research

Broad Institute

Ben Moore

Director of Research

Paros Bio

Benjamin Shykind

Senior Director - Discovery

Prevail Therapeutics

Boaz Levi

Associate Investigator - Human Cell Types

Allen Institute

Brittany Hernandez

Executive Vice President

Crossroad Strategies

Bryn Martin

Vice President, Research, Precision Delivery, & CSF Sciences

Alcyone Therapeutics, Inc

David Huss

Chief Scientific Officer

Shape Therapeutics

Edgar Rodriguez

Chief Executive Officer & Co-Founder

Lacerta Therapeutics

Eliseo Salinas

Chief R&D Officer

Passage Bio

Elizabeth Ramsburg

Head Of Central Nervous System & Research

Spark Therapeutics

Farrah Vogel-Javeri

Research Analyst

Beacon Gene Therapy

Gregory Fuest

Vice President of Marketing & Commercial Strategy

Passage Bio

Heather Lau

Executive Director

Ultragenyx Pharmaceutical

Jacinthe Gingras

Senior Director - Ophthalmology & Neurology

Homology Medicines

Jana Von Hehn

Chief Scientific Officer

Rett Syndrome Research Trust

Jay Barth

Chief Medical Officer

Lexeo Therapeutics

Jennifer Johnston

Cofounder & Chief Executive Officer


Junghae Suh

Vice President, Gene Therapy Accelerator Unit


Karen Kozarsky

Founder Chief Scientific Officer

Swan Bio Therapeutics

Kasia Szczepanska

Executive Director

Global Launch Team, PTC Therapeutics

Ken Mullinix

Head of Surgical Services


Kennon Smith

Lead Scientist - Platform


Kristin Stephenson

Director - Strategy & Alliances

St. Jude Children’s Research Hospital

Laura Jane Smith

Principle Scientist & Scientific Co-founder

Homology Medicines

Lingzhi Zhao

Senior Director - Gene Therapy & Transnational Discovery


Maria Praggastis

Staff Scientist Regeneron


Mark Tuszynski


University of California, School of Medicine

Martin Ingelsson

Professor & Clinician Scientist

Tanz Centre for Research In Neurodegenerative Diseases, University of Toronto

Nathalie Cartier



Peter Pechan

Head of Vector Biology, GTVC

UCB Boston

Rodolphe Clerval

Chief Executive Officer

Coave Therapeutics

Roger Chung

Chief Scientific Officer

Celosia Therapeutics

Ronald Crystal

Founder & Chief Scientific Advisor

Lexeo Therapeutics

Ruby Boyanapalli

Associate Director


Samir Koirala



Serene Forte

Senior Vice President, Head of Genetic Medicine

Relief Therapeutics

Sharyl Fyffe-Maricich

Executive Director - Molecular & Cellular Biology Research


Shyam Ramachandran

Neuroscience Head, Genomic Medicine Unit


Steve Hill

Senior Director Global Market Access & Pricing

PTC Therapeutics

Steven Cohen

Executive Director

Daiichi Sankyo

Steven Gray

Associate Professor; Chief Scientific Adviser

University of Texas Southwestern Medical Center; Taysha Gene Therapies

Suneil Hosmane

VP Clinical & Translational Biomarker Strategy


Thomas Packard

Associate Director

Shape Therapeutics

Zhenpeng Qin

Associate Professor of Mechanical Engineering

University of Texas at Dallas